Andrew Komjathy

Insider Reports History

Entity
Individual
Location
Catabasis Pharmaceuticals, Inc., One Kendall Square, Suite B14202, Cambridge, MA
Signature
/s/ Noah Clauser, as attorney-in-fact for Andrew Komjathy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Komjathy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Astria Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 175K Feb 8, 2024 Direct

Insider Reports Filed by Andrew Komjathy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATXS Astria Therapeutics, Inc. Feb 8, 2024 1 $0 4 Feb 12, 2024 Chief Commercial Officer
ATXS Astria Therapeutics, Inc. Jun 2, 2023 1 $0 4 Jun 6, 2023 Chief Commercial Officer
ATXS Astria Therapeutics, Inc. Mar 1, 2022 1 $0 4 Mar 3, 2022 Chief Commercial Officer
ATXS Astria Therapeutics, Inc. Dec 28, 2021 2 $0 5 Feb 10, 2022 Chief Commercial Officer
ATXS Astria Therapeutics, Inc. Nov 19, 2021 1 $670 4 Nov 23, 2021 Chief Commercial Officer
ATXS CATABASIS PHARMACEUTICALS INC Jun 2, 2021 1 $0 4 Jun 2, 2021 Chief Commercial Officer